← Evidence map

ReviewDrugs2014

Cabozantinib: a review of its use in patients with medullary thyroid cancer.

Sheridan M HoyPubMed ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25056653